Pages that link to "Q30984127"
Jump to navigation
Jump to search
The following pages link to Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. (Q30984127):
Displaying 50 items.
- Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease (Q21131065) (← links)
- Cerebrospinal fluid and blood flow in mild cognitive impairment and Alzheimer's disease: a differential diagnosis from idiopathic normal pressure hydrocephalus (Q22001134) (← links)
- Current status of biomarker research in neurology (Q26744505) (← links)
- The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis (Q26769966) (← links)
- Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging (Q26770766) (← links)
- Type 2 diabetes and cognitive impairment: linking mechanisms (Q26822993) (← links)
- Reevaluating Metabolism in Alzheimer's Disease from the Perspective of the Astrocyte-Neuron Lactate Shuttle Model (Q26864926) (← links)
- Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease (Q26866392) (← links)
- Imaging markers for Alzheimer disease: which vs how (Q27001254) (← links)
- Brain PET in the diagnosis of Alzheimer's disease (Q27011549) (← links)
- Neuroimaging biomarkers of neurodegenerative diseases and dementia (Q27691820) (← links)
- Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling (Q28076999) (← links)
- Beneficial network effects of methylene blue in an amnestic model. (Q28385923) (← links)
- Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains (Q28392337) (← links)
- Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniques (Q28395854) (← links)
- Distinct pools of non-glycolytic substrates differentiate brain regions and prime region-specific responses of mitochondria (Q28534698) (← links)
- New Computer-Aided Diagnosis of Dementia Using Positron Emission Tomography: Brain Regional Sensitivity-Mapping Method (Q28744562) (← links)
- Neuroimaging of individuals with Down’s syndrome at-risk for dementia: Evidence for possible compensatory events (Q30051683) (← links)
- Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis (Q30399994) (← links)
- Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer. (Q30403393) (← links)
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (Q30458193) (← links)
- Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice. (Q30506148) (← links)
- A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease (Q30538459) (← links)
- Neuronuclear imaging in the evaluation of dementia and mild decline in cognition (Q30571571) (← links)
- Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice (Q30573779) (← links)
- The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies (Q30830414) (← links)
- What have novel imaging techniques revealed about metabolism in the aging brain? (Q30850844) (← links)
- Current status and future role of brain PET/MRI in clinical and research settings (Q30883711) (← links)
- Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease (Q30913572) (← links)
- Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions (Q30998279) (← links)
- Human gene therapy and imaging in neurological diseases (Q31023442) (← links)
- Brain imaging in dementia (Q31051218) (← links)
- Brain profile of hypometabolism in early Alzheimer's disease: relationships with cognitive deficits and atrophy (Q31065297) (← links)
- Imaging, subjective complaints, and MCI: 30 years before (Q31141568) (← links)
- Concept of functional imaging of memory decline in Alzheimer's disease (Q31150981) (← links)
- Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease (Q33520683) (← links)
- Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions (Q33556006) (← links)
- Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease (Q33581218) (← links)
- Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies (Q33590723) (← links)
- Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease (Q33663207) (← links)
- Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer's disease: a cross-sectional study (Q33691776) (← links)
- Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms (Q33720033) (← links)
- Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. (Q33726019) (← links)
- Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients (Q33728851) (← links)
- Quantitative structural MRI for early detection of Alzheimer’s disease (Q33729033) (← links)
- 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons (Q33740879) (← links)
- Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons (Q33762153) (← links)
- Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease (Q33764303) (← links)
- Latent feature representation with stacked auto-encoder for AD/MCI diagnosis (Q33787457) (← links)
- The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model (Q33795218) (← links)